GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » Ending Cash Position

ISU Abxis Co (XKRX:086890) Ending Cash Position : ₩24,945 Mil (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is ISU Abxis Co Ending Cash Position?

ISU Abxis Co's Ending Cash Position for the quarter that ended in Dec. 2024 was ₩24,945 Mil.

ISU Abxis Co's quarterly Ending Cash Position increased from Jun. 2024 (₩9,424 Mil) to Sep. 2024 (₩29,139 Mil) but then declined from Sep. 2024 (₩29,139 Mil) to Dec. 2024 (₩24,945 Mil).

ISU Abxis Co's annual Ending Cash Position increased from Dec. 2022 (₩21,095 Mil) to Dec. 2023 (₩96,330 Mil) but then declined from Dec. 2023 (₩96,330 Mil) to Dec. 2024 (₩24,945 Mil).

ISU Abxis Co Ending Cash Position Historical Data

The historical data trend for ISU Abxis Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ISU Abxis Co Ending Cash Position Chart

ISU Abxis Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,463.91 14,347.34 21,095.06 96,329.91 24,944.71

ISU Abxis Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96,329.91 20,828.15 9,424.37 29,138.99 24,944.71

ISU Abxis Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ISU Abxis Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=96329.907+-71385.201
=24,945

ISU Abxis Co's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=29138.992+-4194.286
=24,945

ISU Abxis Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of ISU Abxis Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ISU Abxis Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » Ending Cash Position
Comparable Companies
XKRX:203400 XKRX:011000 XKRX:002630 XKRX:353810 XKRX:065660 XKRX:394800 XKRX:174900 XKRX:060590 XKRX:138610 XKRX:323990 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
3Fl. Kookje Bldg, 90-1 Daeshin-dong, Seodaemun-gu, Seoul, KOR, 120-160
Website
http://www.abxis.com
ISU Abxis Co Ltd is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.

ISU Abxis Co Headlines

No Headlines